Abstract
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the digestive tract (80%). The stomach is the most commonly affected organ. Complete resection of the tumor is the only curative treatment. The size and number of mitoses are parameters to determine the prognosis and the use of adjuvant therapies. Although sometimes the GIST is giant it should be completely resected and if possible the stomach reconstructed to preserve function and quality of life.
Reference14 articles.
1. Ridolfini MP, Cassano A, Ricci R, et al. Gastrointestinal stromal tumors. Ann Ital Chir. 2011;82(2):97-109.
2. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004;Cho;J Korean Med Sci,2010
3. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up;Miettinen;Am J Surg Pathol,2005
4. Tumores del estroma gastrointestinal: breve actualización y consenso de la SEAP-SEOM sobre diagnóstico patológico y molecular;González;Revista Española de Patología,2017
5. Bucher P, Villiger P, Egger JF, et al. Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly. 2004;134(11-12):145-153.